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Zygotic gene activation is essential for development beyond the 2-cell stage in the preimplantation mouse embryo. Based on a-amanitin-
sensitive BrUTP incorporation, transcription initiates in the 1-cell embryo and a major reprogramming of gene expression driven by newly
expressed genes is prominently observed during the 2-cell stage. Superimposed on genome activation is the development of a
transcriptionally repressive state that is mediated at the level of chromatin structure. The identity of the genes that are expressed during the
1- and 2-cell stages, however, is poorly described, as are those genes involved in mediating the transcriptionally repressive state. Using the
Affymetrix MOE430 mouse GeneChip set, we characterized the set of a-amanitin-sensitive genes expressed during the 1- and 2-cell stages,
and we used Expression Analysis Systematic Explorer (EASE) and Ingenuity Pathway Analysis (IPA) to identify biological and molecular
processes represented by these genes, as well as interactions among them. We find that although the 1-cell embryo is transcriptionally active,
we did not detect any transcripts present on the MOE430 GeneChip set to be a-amanitin-sensitive. Thus, what the BrUTP incorporation
represents remains elusive. About 17% of genes expressed in the 2-cell embryo are a-amanitin-sensitive. EASE analysis reveals that genes
involved in ribosome biogenesis and assembly, protein synthesis, RNA metabolism and transcription are over-represented, suggesting that
genome activation during 2-cell stage may not be as global and promiscuous as previously proposed. IPA implicated Myc and Hdac1 as
candidate genes involved in genome activation and the development of the transcriptionally repressive state, respectively.
D 2005 Elsevier Inc. All rights reserved.Keywords: Microarray; Gene expression; Zygotic gene activation; Preimplantation mouse embryoIntroduction
Zygotic gene activation (ZGA) is the first major
developmental event that occurs following fertilization
(Schultz, 2002). Meiotic maturation initiates degradation
of most maternal mRNAs and is essentially complete by the
late 2-cell stage in mouse. For oocyte-specific transcripts,
such as H1foo (Tanaka et al., 2001) and Msy2 (Yu et al.,
2001) that are not re-expressed later in development,
destruction of these maternal mRNAs restricts the length
of time that these genes can function. For transcripts that are
common to both the oocyte and embryo, for example, actin,
ZGA is essential for replacing the degraded maternal
transcripts with zygotic transcripts. ZGA is also responsible0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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E-mail address: rschultz@sas.upenn.edu (R.M. Schultz).for the dramatic reprogramming of gene expression that
occurs during the 2-cell stage in mouse and likely drives the
conversion of the highly differentiated oocyte into totipo-
tent 2-cell blastomeres. ZGA is essential for development
because 2-cell embryos do not cleave when cultured in the
presence of a-amanitin, which inhibits RNA polymerase II
activity.
Although genome activation is clearly evident in 2-cell
embryos, transcription initiates during the 1-cell stage as
assessed by either BrUTP incorporation (Aoki et al., 1997;
Bouniol et al., 1995) or expression of a plasmid-borne
reporter gene (Ram and Schultz, 1993). In both cases, the
male pronucleus (PN) supports a higher level of trans-
cription than the female PN (Aoki et al., 1997; Wiekowski
et al., 1993). Moreover, the level of transcription is
significant in the late 1-cell embryo, reaching 30-40% that
observed in the late 2-cell embryo (Aoki et al., 1997).283 (2005) 40 – 57
F. Zeng, R.M. Schultz / Developmental Biology 283 (2005) 40–57 41Nevertheless, expression of only MuERV-L (a repetitive
element and as such may not be reflective of single-copy
genes) in 1-cell embryos has been reported to date
(Hamatani et al., 2004). Expression of a h-actin promoter-
driven luciferase transgene has also been observed in 1-cell
embryos (Kigami et al., 2003). Because the absolute level of
transcript abundance was not quantified in these reports, it
has not been established that their expression represents
mature transcripts capable of being translated.
Transcription and translation may be uncoupled in the
1-cell embryo (Nothias et al., 1996). Consistent with this
proposal is that luciferase activity is detected several hours
after expression of the luciferase transgene (Matsumoto et al.,
1994), that is, the transcript is detected in 1-cell embryos but
the protein is first detected in 2-cell embryos. Thus, the
ability of the 1-cell embryo to generate functional transcripts,
that is, transcripts that are spliced, capped, polyadenylated,
transported to the cytoplasm, and translated is unresolved.
Superimposed on genome activation is the development
of a chromatin-based transcriptionally repressive state
during the 2-cell stage and the requirement for an enhancer
for efficient gene expression of a plasmid-borne reporter
gene (Aoki et al., 1997; Davis et al., 1996; Henery et al.,
1995; Ma et al., 2001; Majumder et al., 1993). This rep-
ression and enhancer requirement are relieved by inducing
histone acetylation or by inhibiting the second round of
DNA replication. Chromatin remodeling that occurs during
the 1- and 2-cell stages has been proposed to provide a
window of opportunity for transcription factors to gain
access to their cis-cognate DNA-binding sequences (Ma et
al., 2001). Thus, any gene whose promoter is accessible and
for which the relevant transcription factors exist would be
transcribed. This may account, at least in part, for the high
incidence of transcripts derived from repetitive elements in
the 2-cell embryo (Evsikov et al., 2004; Svoboda et al.,
2004). A function of the transcriptionally repressive state
would be to repress transcription of such opportunistically
expressed genes and sculpt an expression profile compatible
with development in which genes that use a strong promoter
or enhancer are expressed. In addition, development is
accompanied by a more efficient use of TATA-less
promoters (Davis and Schultz, 2000; Majumder and
DePamphilis, 1994), which may also play a role in estab-
lishing the appropriate pattern of gene expression required
for development.
Recent studies using microarrays, however, suggest that
genome activation may not be as promiscuous as previously
envisioned (Hamatani et al., 2004; Wang et al., 2004; Zeng
et al., 2004), but rather far more selective with genes
involved in transcription and RNA processing being
preferentially expressed (Zeng et al., 2004). What remains
elusive is identifying the genes that are transcribed at the
onset of ZGA-perhaps genes critical for the sustaining ZGA-
and the development of the transcriptionally repressive state.
We report here the transcript profiles in 1-cell and 2-cell
mouse embryos treated with a-amanitin to identify genesthat are activated during the course of ZGA. We then used
Expression Analysis Systematic Explorer (EASE) analysis
and Ingenuity Pathway Analysis to identify major biological
themes that occur during ZGA and to predict key networks
of genes that function during this developmental transition.Materials and methods
Embryo collection and culture
One-cell mouse embryos were collected from super-
ovulated female CF-1 mice (Harlan) mated to B6D2F1/J
males (Jackson Laboratory) as previously described (Aoki
et al., 1997). The embryos were cultured in KSOM plus
amino acids (abbreviated as KSOM) in an atmosphere of
5% O2/5% CO2/90% N2 at 37-C (Erbach et al., 1994; Ho et
al., 1995). For the metabolic labeling and splicing study,
embryos were synchronized by culling them as previously
described (Ram and Schultz, 1993). To block RNA
polymerase II-dependent transcription, a-amanitin (Sigma-
Aldrich) was added to the culture medium at a final
concentration of 24 Ag/ml at the time points indicated in
the text and Fig. 2.
For microarray studies, unfertilized eggs were collected
from superovulated female CF-1 mice at 14–16 h post-hCG
as previously described (Endo et al., 1987). One-cell
embryos were collected (see above) at 14–16 h post-hCG
and cultured in KSOM with or without a-amanitin prior to
PN formation to insure that transcription was inhibited;
fertilization occurs ¨12 h post-hCG, and PN formation
around 5–7 h post-fertilization (Moore et al., 1996).
Embryos were then recovered from the culture dishes at
24 h (1-cell) and 44 h post-hCG (2-cell), which corresponds
to S in the 1-cell and G2 in the 2-cell, respectively. Four
pools of embryos (¨325 eggs, 335 1-cell and 380 2-cell per
pool) from each stage/treatment were collected from
separate sets of fertilized mice. The samples were then
processed for microarray analysis as described below.
[35S] methionine metabolic labeling of mouse embryos
Synchronized 2-cell embryos obtained by culling were
metabolically radiolabeled in KSOM without amino acids
but containing 1 mCi/ml [35S]methionine (1500 Ci/mmol,
Amersham) for 3 h from 42 to 45 h post-hCG (which
corresponds to G2) in the presence or absence of a-
amanitin. The radiolabeled samples were then subjected to
SDS-PAGE (10% gel); samples with equal numbers of acid-
insoluble cpm were applied to each lane. Radiolabeled
proteins were detected using a phosphorimager.
Microinjection of 1-cell embryos
One-cell embryos (collected at 16–18 h post-hCG) that
developed a PN within a 30-min period were culled and
F. Zeng, R.M. Schultz / Developmental Biology 283 (2005) 40–5742incubated in KSOM. The male PN of 1 cell embryos was
microinjected 4 h after PN formation (early S phase), and
either one or both nuclei of 2 cell embryos was injected 19–
20 h (early S phase) or 24 h (late S phase) after PN
formation. The PN or nuclei were injected with 2–10 pl of a
10-ng/Al solution of a pGL2-Control plasmid (Promega) in
10 mM Tris–HCl, pH 7.6, containing 0.1 mM EDTA as
previously described (Ram and Schultz, 1993). Approxi-
mately 3–15,000 copies of the plasmid were injected.
Control embryos were injected with 5 pl of H2O. The
microinjected embryos were than transferred to and cultured
in KSOM; ¨75% of the injected embryos routinely
survived the injection procedure. Embryos were then
recovered at late G2 of the 1-cell or 2-cell stage (13 h and
40 h after injection, respectively) for subsequent RNA
extraction and RT-PCR analysis.
RNA extraction and RT-PCR
Total RNA was extracted from embryos in 150 Al of
Trizol (Invitrogen) containing 20 Ag of rRNA or glycogen
as carrier. RT-PCR for the splicing study was performed as
previously described (Zeng and Schultz, 2003), except
nested PCR was performed. The primers used were A [5V-
GCCTGGTGCTACGCCTGAATAA-3V], D [5V-CCA-
CCACTGCTCCCATTCATCA-3V] and E [5V-GTCAGC-
AGTAGCCTCATCATC-3V]. Ten embryo equivalents of
template RNA was used for the first PCR with primers A
and E for 20 cycles (95-C for 10 s and 60-C for 15 s), 1/10
of which was subjected to a second nested PCR with
primers A and D for 32 cycles (95-C for 15 s, 58-C for 30 s,
and 72-C for 1 min). PCR products were visualized on a 3%
(3:1) NuSieve Agrose gel, followed by gel extraction of the
specific fragments (Qiagen) for sequencing analysis.
Real-time RT-PCR analysis was performed with the ABI
TaqMan Assay-on-Demand probe/primer set (Zeng et al.,
2004) Mm00487803_m1 (Myc), as well as the ABI TaqMan
Assay-by-Design probe/primer sets for MuERV-L and
Hdac1. Two embryo equivalents of template RNA were
used for each real-time PCR reaction with a minimum of
three replicates (from independently collected embryos per
replicate) as well as a minus RT and minus template controls
for each gene. Quantification was normalized to exoge-
nously added GFP mRNA that was added in equal amounts
per embryo equivalent during RNA extraction (Anger et al.,
2005), using the comparative CT method (ABI PRISM 7700
Sequence Detection System, user bulletin #2).
Microarray analysis
Total RNA from 4 replicates of each embryo stage/
treatment was used for linear, two-round amplification by
in vitro transcription and target cRNA preparation accor-
ding to the Affymetrix Small Sample Prep Technical
Bulletin (www.affymetrix.com). Fifteen Ag per replicate of
fragmented cRNA samples were serially hybridized toMOE430A and MOE430B GeneChips, then processed
according to the manufacturer’s instructions (GeneChip
Analysis Technical Manual, www.affymetrix.com) at the
Penn Microarray Facility.
Microarray analysis was performed as described in detail
in Zeng et al. (2004), and the resulting data from this and our
previous study are available at the Gene Expression Omnibus
(www.ncbi.nlm.nih.gov/geo). Briefly, Microarray Analysis
Suite 5.0 (MAS, Affymetrix) was first used to quantify
microarray signals with default analysis parameters and
global scaling to target mean = 150. The MAS metrics output
was then loaded into GeneSpring v6 (Silicon Genetics) with
per chip normalization to the 50th percentile and per-gene
normalization to the median. A non-redundant, filtered list
was created of all genes detected (MAS ‘‘P’’ call) in at least
three of four replicates in at least one embryo stage/treatment
(called ‘‘all genes detected’’ below). K-mean hierarchical
clustering with this gene list, as well as all genes on the
MOE430 chip set, was used to construct clustering dendo-
grams to visualize inter-relationships between different
embryo samples. The MAS metrics output of all genes on
the GeneChip set after GeneSpring normalization was also
used for a one-way ANOVA analysis for microarrays (default
parameters with a FDR <5%), as well as Principle Compo-
nent Analysis (PCA) (default parameters except 2-fold
change threshold for clusters) using the NIA Array Analysis
Tool (http://lgsun.grc.nia.nih.gov/ANOVA/index.html).
The GeneSpring ‘‘filter on fold change’’, ‘‘filter on
flags’’, and ‘‘draw gene’’ tools were applied to the statisti-
cally significant candidate lists to locate genes that showed
different characteristics and patterns (e.g., genes that are a-
amanitin-sensitive in the 2-cell cultured embryo and also
present with at least 5-fold higher expression in in vivo
developed 2-cell compared to 1-cell). For simplicity, the
following abbreviations are used throughout: 1CC or 2CC
refer to 1-cell or 2-cell embryos cultured in KSOM; 1CA or
2CA refer to 1-cell or 2-cell embryos cultured in KSOM +
a-amanitin; 1C and 2C refer to 1-cell or 2-cell embryos
developed in vivo with minimal manipulation in vitro. Note
that MAS output data from our previous microarray studies
of in vivo developed 1- and 2-cell embryos were included
for GeneSpring analyses, as well as used for ANOVA
analysis to generate expression profiles of genes in different
conditions/treatment. We used in vitro samples only as the
first filter and to identify candidate genes that are
a-amanitin-sensitive, and to place these candidates in a
biological context, we also compared the in vivo sample set
in eggs, 1-cell and 2-cell embryos. At no time were in vivo
and in vitro samples directly compared to each other and
used to generate statistically significant gene lists. Lists of
candidate genes generated from these pattern searches were
then imported to EASE v2.0 to test for overrepresentation of
biological processes in each subset list (Hosack et al., 2003).
EASE analysis with Bonferroni multiplicity correction
tested each subset list against their corresponding population
lists (e.g., all non-redundant genes detected), and an EASE
Table 1
Number of genes detected in in vivo developed and in vitro treated 1-cell
and 2-cell embryos
Condition Genes
detected
a-amanitin-
sensitive
a-amanitin-sensitive
and detected
1-cell in vivo 9340 – 0
1-cell culture 10422 1 0
1-cell + a-am 10262 – –
2-cell in vivo 10579 – 1464
2-cell culture 10597 2607 1819
2-cel + a-am 8906 – –
Total 13679
The number of genes detected (Affymetrix ‘‘P’’ call in at least 3 of 4
replicates) on the MOE430A and B GeneChips in each stage/treatment, as
well as the total number of non-redundant genes detected from all six
conditions, are listed in the second column. One-way ANOVAwas used to
identify genes showing a statistically significant expression difference
between a-amanitin-treated and untreated 1- and 2-cell embryos and the
resulting number of genes is listed in the third column. This a-amanitin-
sensitive gene list is then filtered against the list of genes that are detected in
1- and 2-cell embryos and the subset is listed in the fourth column. See
Supplementary Table S1 for the list of a-amanitin-sensitive genes.
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the Gene Ontology Consortium annotation categories GO
biological process, GO cell component and GO molecu-
lar function, as well as KEGG pathways and SwissProt
keywords.
Ingenuity Pathways Analysis (IPA) version 2.0 was used
to search for possible biological pathways and the inter-
relationships between network genes in the subsets of
candidate genes with particularly interesting patterns. A
detailed description of IPA can be found on www.Ingenuity.
com. Data sets containing the Affymetrix gene identifiers
and their corresponding expression fold-change values, and
P values from ANOVA analysis were uploaded as tab-
delimited text files. Each gene identifier was mapped to
its corresponding gene object in the Ingenuity Pathways
Knowledge Base. A fold-change cutoff of at least 1.4 was
set between stage/treatment to filter further the genes whose
expression was significantly differentially regulated. These
genes, called Focus Genes, were then used as the starting
point for generating biological networks.
To start building networks, the program queries the
Ingenuity Pathways Knowledge Base for interactions
between Focus Genes and all other gene objects stored in
the knowledge base, and generates a set of networks. IPA
then computes a score for each network according to the fit
of the network to the set of focus genes. The score is the
negative log of a P value and indicates the likelihood of the
Focus Genes in a network being found together due to
random chance. A score of 2 indicates that there is a 1 in
100 chance that the Focus Genes are together in a network
due to chance, a score of 3 corresponds to 1 in 1000, and so
forth. Therefore, scores of 2 or higher represent a 99%
confidence level. Biological functions are then calculated
and assigned to each network.
It should be noted that a recent study reported that many
transcripts expressed in oocytes (and hence 1-cell embryo)
and 2-cell embryos are chimeric in which an LTR class III
retrotransposon sequence is located at the 5Vend (Peaston et
al., 2004); the function of these transcripts in preimplanta-
tion development remains unresolved. The microarrays used
here do not discriminate between these transcripts and their
bona fide counterparts because the array probes used are
biased towards the 3Vend of the transcript.
Cross-platform analysis
The mapping between the Affymetrix MOE430 Gene-
Chip set and the NIA 22K oligomer microarray platforms
were determined by using BLASTN with default parameters
to compare each NIA oligomer to a database of MOE430
consensus sequences (downloaded from NetAffx). Blast
matches greater than or equal to 55 bp in length and greater
than or equal to 95% identity were considered to represent
the same gene. This mapping was then used as input to a
Perl script that compares the a-amanitin-sensitive genes
between this study and the combined, non-redundant a-amanitin-sensitive genes from all time points from the
Hamatani study (Hamatani et al., 2004) to identify the
overlapping set (or concordance) between the two studies.Results and discussion
Hierarchical cluster analysis and identification of
a-amanitin-sensitive gene sets
We previously determined that following fertilization
there are increases in relative transcript abundance of many
transcripts in 1-cell embryos (Zeng et al., 2004). Many of
these changes are likely due to recruitment of maternal
mRNAs that entails polyadenylation and would result in
more efficient dT priming, and hence an apparent increase
in relative abundance. Nevertheless, given that the 1-cell
embryo is transcriptionally active, it is also possible that
some of these increases are due to transcription. In addition,
results of numerous studies indicate that transcription is
responsible for many of the changes in gene expression that
occur during the 2-cell stage (e.g., Latham et al., 1991). To
identify these newly expressed genes, we analyzed the
transcript profiles in 1- and 2-cell embryos that had been
cultured in the presence of a-amanitin. Because culture can
influence the pattern of gene expression (Christians et al.,
1995; Rinaudo and Schultz, 2004), we included microarray
data sets of 1-cell and 2-cell embryos that developed in vivo
from our previous study (Zeng et al., 2004) in the analysis
presented here.
An unsupervised hierarchical clustering using either all
the transcripts on the MOE430 chip set or the non-redundant
list of transcripts that are expressed in the early preimplanta-
tion embryos (Table 1) was constructed using microarray
data from in vitro treated embryos and 1- and 2-cell embryos
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2-cell embryos clustered separately. The sub-clustering of
2-cell embryos that developed in vitro or in vivo likely
represents the effect of culture on gene expression and thatFig. 1. Hierachical clustering and PCA analysis. (A) Hierachical clustering
analysis of all samples from different developmental stages or treatments.
Unsupervised clustering in GeneSpring was used to analyze similarities
among replicate samples across all stages tested. Replicate samples are
indicated at the bottom of the figure. Colors correspond to relative RNA
abundance for the 13,679 transcripts (Unigene accessions) detected
(Affymetrix ‘‘Present’’ call), each of which is represented by a horizontal
bar. 1CC and 2CC refer to 1-cell and 2-cell embryos cultured in KSOM;
1CA and 2CA refer to 1-cell or 2-cell embryos cultured in KSOM
containing a-amanitin; 1C and 2C refer to 1-cell and 2-cell embryos that
developed in vivo. (B) Principal component analysis of gene expression of
all groups as in the hierarchical clustering analysis.development in vitro lags development in vivo. For example,
the increase in Hsp70.1 expression that occurs between the
1- and 2-cell stages is much greater when the 1-cell embryos
are cultured (Christians et al., 1995). Also anticipated is that
2-cell embryos cultured in the presence of a-amanitin (2CA)
clustered with the 1-cell rather than the 2-cell embryos
because the transcripts present in these treated 2-cell
embryos are mainly of maternal origin.
One-cell embryos that developed in vivo clustered
separately from those that developed in vitro in either the
presence or absence of a-amanitin. As with 2-cell embryos,
this likely was due to processes such as maternal mRNA
degradation occurring with different kinetics than in
embryos developing in vivo. Of note, however, was that
the replicates of 1-cell cultured embryos did not cluster
according to the presence or absence of a-amanitin treat-
ment, but rather clustered into one large tree branch. Thus,
all the replicates of these 1-cell embryos, regardless of
a-amanitin treatment, showed very similar gene expression
patterns. This implies that although the 1-cell embryo is
transcriptionally active, few poly (A)-containing transcripts
are generated. The failure to detect a-amanitin-sensitive
transcripts cannot be attributed to the ineffectiveness of
a-amanitin to inhibit transcription in 1-cell embryos. Real-
time PCR analysis of MuERV-L, which is transcribed in the
1-cell stage (Hamatani et al., 2004; Kigami et al., 2003),
showed that a 4.5-fold increase occurs between the egg and
1-cell stage, and in the presence of a-amanitin this increase
is 1.6-fold, that is, a 65% decrease in level of expression in
the a-amanitin-treated embryos. Thus, the cluster analy-
sis suggests little de novo transcription from the zygotic
genome in 1-cell embryos.
Principle Component Analysis (PCA) confirmed the
relationships between the samples from different treatments
and stages of the embryos (Fig. 1B). The 1CC/1CA and
2CA resided closer to 1C in the PC2/PC3 plane, the 2CC
and 2C were closer to each other and towards the opposite
PC2/PC3 plane, and the 1C and 2C were grouped against
PC1/PC2 plane with respect to other groups. Thus, the
concordance of the hierarchical cluster analysis and the PCA
analysis with previous results collected by totally indepen-
dent methods provides confidence in conclusions drawn
from these microarray data sets. (See below for further
discussion on the concordance of the two studies.)
One-way ANOVA analysis using Affymetrix MAS
output data after GeneSpring normalization was used to
search for the a-amanitin-sensitive candidate genes that are
statistically different between a-amanitin-treated vs. control
embryos. Table 1 lists the number of transcripts that are
detected (using GeneSpring filter on ‘‘Flag’’ according to
the Affymetrix ‘‘P’’ call) on the MOE430 GeneChip set and
the number of a-amanitin-sensitive transcripts in 1- and
2-cell embryos. In contrast to the expected large number
of a-amanitin-sensitive transcripts detected in the 2-cell
(discussed below) and consistent with the cluster analysis,
no a-amanitin-sensitive transcripts were detected in the
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different platform of long oligomer arrays derived from
cDNA libraries to analyze expression profiles of a-amanitin-
treated embryos only detected 1 de novo transcript in 1-cell
embryos, MuERV-L (M. Ko, personal communication).
Thus, recruitment of maternal mRNAs is likely responsible
for our detecting¨1500 transcripts that are expressed higher
in the 1-cell embryo when compared to other stages of
preimplantation development (Zeng et al., 2004).
TRC expression in the 1-cell embryo
Given that the extent of BrUTP incorporation by 1-cell
embryos is ¨30–40% that of a 2-cell embryo (Aoki et al.,
1997), the failure to detect a family of a-amanitin-sensitive
transcripts in the 1-cell embryo using microarrays highlights
the conundrum as to what the transcription in the 1-cell
embryo represents, for example, are bona fide transcriptsFig. 2. TRC expression in 1-cell embryos. (A) Schematic of the time-course of the
adapted from Moore et al. (1996). PN, pronucleus formation. (B) TRC expression
mid 2-cell stage (45 h post-hCG). Lane 1, control embryos; lanes 2–4, 1-cell embry
fertilization (G2/M of the 1-cell stage). The position of the TRC is indicated by the
obtained in each case; shown is a representative example.actually made? As an alternative approach, we examined if
transcripts for the transcription-requiring complex (TRC)
are expressed in the 1-cell embryo. The TRC, which is
a-amanitin-sensitive, is an accepted marker for ZGA and
encodes a family of structurally-related proteins of Mr =
70,000 (Conover et al., 1991). Its identity, however, is not
known, and hence the TRC might not be properly annotated
or present on the Affymetrix MOE430 GeneChip. TRC
expression, which can be detected as early as 2–3 h following
cleavage to the 2-cell stage, constitutes 4–6% of total protein
synthesis in 2-cell embryos (Conover et al., 1991) and hence
its transcripts are likely expressed at reasonably high levels.
Because the TRC protein synthesis is rapidly detected
following cleavage to the 2-cell stage, we examined whether
this synthesis results from translation of TRC transcripts
expressed in the 1-cell embryo but not yet translated due to
the uncoupling of transcription and translation (Nothias
et al., 1996) (Fig. 2). One-cell embryos were cultured in theexperimental treatment. The time line of the first and second cell cycles was
in metabolically radiolabeled embryos. All embryos were radiolabeled at the
os cultured in KSOM containing a-amanitin starting at 5, 17, and 18 h post-
bracket. The experiment was performed three time and similar results were
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hCG) at which time they were transferred to KSOM con-
taining a-amanitin. Following cleavage to the 2-cell stage,
the embryos were assessed for TRC synthesis.
Following addition of a-amanitin to 1-cell embryos at a
time corresponding to the late G2 stage of the 1-cell embryo,
no TRC synthesis was observed in the 2-cell embryos, as
was also the case with embryos cultured in a-amanitin from
the early 1-cell stage. In contrast, TRC expression was
readily observed in the untreated control 2-cell embryos.
Thus, it is unlikely that functional TRC transcripts–
transcripts that are expressed, processed, transported to the
cytoplasm and translated–are expressed in the 1-cell
embryo. We cannot exclude, however, that TRC transcripts
were degraded by the time of metabolic radiolabeling.
Splicing competence in the 1-cell embryo
Our inability to detect a set of a-amanitin-sensitive
transcripts in 1-cell embryos could be due to deficiencies in
transcription and processing, export, and mRNA stability. It
is unlikely that the newly synthesized transcripts are so
rapidly degraded as not to be detected. Although mRNA
injected into 1-cell embryos can be degraded ¨65-fold
faster than mRNA injected into oocytes (Ebert et al., 1984),
the detection of TRC synthesis in G2 of the 1-cell em-
bryo following transplantation of a 2-cell nucleus to an
enucleated 1-cell embryo (Latham et al., 1992) suggests
rapid degradation of nascent transcript is less likely the case
in 1-cell embryo. Furthermore, this result also suggests that
the late 1-cell embryos can support transcription once ZGA
initiates. Thus, a more likely cause for the lack of functional
transcripts in 1-cell embryos are defects or inefficiencies in
transcription, mRNA processing or mRNA export.
An RNA transcript undergoes four major interlinked
processing events–capping, splicing, cleavage, and poly-
adenylation–before it becomes a translatable mRNA that is
exported from the nucleus (Lee and Young, 2000). More-
over, these processes are directly associated with RNA
polymerase II (Pol II) at all three stages of transcription, that
is, initiation, elongation, and termination. Deficiencies in
one or more of these events could produce transcripts
lacking a poly(A) tail. Such transcripts would not be
amplified by our protocol and hence could account for our
failure to detect expression of a-amanitin-sensitive 1-cell
transcripts. Although MuERV-L is expressed in the 1-cell
embryo, it is intronless, and hence splicing is not required
for generating functional transcripts. MuERV-L is also a
multicopy element and its transcriptional regulation may not
reflect that of single-copy genes. Plasmid-borne reporter
genes (Ram and Schultz, 1993) or transgenes (Matsumoto
et al., 1994) expressed in 1-cell embryos have introns, but
splicing was not evaluated in the 1-cell embryo. Thus, we
examined if deficiencies in splicing could serve as the
molecular basis for our failure to detect a-amanitin-sensitive
transcripts in 1-cell embryos.A plasmid-borne reporter gene (pGL2-Control plasmid)
containing the SV40 small intron in the 3VUTR (Fig. 3A)
was microinjected into the male PN of 1-cell embryos at G1/
early S phase. The spliced products (172 bp and 243 bp)
were detected in 1-cell embryos in G2 by RT-PCR using
specific primer pairs that flank the intron (Fig. 3B, lane 1).
The spliced products were also detected when the plasmid
was injected in the 2-cell early S phase and assayed at the
2-cell late G2 stage (Fig. 3B, lane 3), but not if assayed at
the late S/early G2 (data not shown). DNA sequencing
analysis confirmed the identity of the 172 bp and 243 bp
fragments obtained from 1-cell embryos. It is therefore
unlikely that failure to detect a-amanitin-sensitive tran-
scripts in 1-cell embryos is due to a deficiency in splicing.
One-cell embryos possess functional RNA polymerase II
(Latham et al., 1992), in which a significant fraction of
the hyperphosphorylated carboxy-terminal domain of the
largest subunit observed in the egg is dephosphorylated 22 h
post-hCG (Bellier et al., 1997). However, deficiencies in
some core components of the transcription machinery or
various elongation/cleavage factors could result in either
premature termination or failure to terminate. In either
case, this could account for the significant amount of
BrUTP incorporation that is observed and the failure to
generate poly(A)-containing transcripts that would be
amplified. Clearly, deficiencies in transcription and pro-
cessing, including initiation, elongation, and termination,
need to be examined further. Of note is that our micro-
array data reveal that among genes that are a-amanitin-
sensitive in vitro, those related to RNA transcription
elongation (Ercc3, Gtf2f1), RNA processing (Prpf4b,
Cstf1), splicing (Ddx20, Gemin5, Sip1, Snrpd2), and
polyadenylation (Cpsf5) also increase between the 1- and
2-cell stages in vivo.
RNA polymerase II is also responsible for transcription
of several snRNAs (Henry et al., 1998), which are involved
in splicing, and snoRNAs (Gerbi, 1995), which are involved
in pre-ribosomal RNA processing and post-transcriptional
modification. We are currently ascertaining if the observed
BrUTP incorporation in 1-cell embryos is due to expression
of these RNAs that are not polyadenylated. If so, enhanced
expression of snRNAs and snoRNAs, coupled with up-
regulation of genes involved in producing functional trans-
cripts (see above), may serve to prepare the embryo for the
major onset of ZGA in the 2-cell embryo.
Identification of biological themes from over-represented
annotation categories for 2-cell nascent transcripts
In contrast to the 1-cell embryo, the major period of
ZGA and reprogramming of gene expression unequivo-
cally occurs during the 2-cell stage, and microarray
analyses have highlighted the extent of this reprogramming
(Hamatani et al., 2004; Wang et al., 2004; Zeng et al.,
2004). These studies demonstrated robust and dynamic
patterns of gene expression during early mouse develop-
Fig. 3. Splicing competence of 1-cell embryos. (A) pGL2-Control plasmid and experimental design to detect splicing by nested PCR. The plasmid map was
adapted from Promega technical manual. (B) Detection of splicing products in 1-cell or 2-cell embryos microinjected with the pGL2-Control plasmid. Lanes 1
and 2, 1-cell embryo injected during G1/early S phase and detected in late G2; lanes 3 and 4, 2-cell embryo injected during G1/early S phase and detected in
late G2; lanes 5 and 6, 1-cell control embryo injected with H2O and assayed at the same time point as in lanes 1 and 2. RT, + or  refer to samples that were
either reversed transcribed (+) or not (). The experiment was performed twice and similar results were obtained in each instance. The presence of bands in
the RT sample are due to residual plasmid DNA that survived the DNase I treatment.
F. Zeng, R.M. Schultz / Developmental Biology 283 (2005) 40–57 47ment, identified large numbers of genes, and predicted
relevant biological programs/themes and signal pathways
in each stage of development including the 2-cell stage.We extended our previous microarray analysis on trans-
cript profiles in preimplantation embryos by identifying
a-amanitin-sensitive genes in 2-cell embryos (Table 1).
Table 3
Selected processes over-represented in a-amanitin-sensitive 2-cell
transcripts
Over-represented categories EASE score No. of
genes
Ribosome biogenesis and assembly 2.84E-14 36
rRNA processing 1.65E-02 9
Biosynthesis—protein biosynthesis 2.00E-12 101
(A) Protein metabolism 2.42E-04 234
Protein folding 1.95E-03 19
(B) Translation—translational initiation 1.14E-02 13
Nucleic acid metabolism 1.61E-07 264
Nucleoside/ribonucleoside
monophosphate biosynthesis
1.39E-02 6
RNA metabolism-RNA processing 7.75E-12 67
mRNA processing 2.48E-06 37
(1) RNA splicing 5.17E-04 25
(2) mRNA splicing 1.04E-03 23
Transcription 3.72E-04 165
(A) Transcription, DNA-dependent 1.05E-02 147
(B) Transcription from Pol I promoter 2.82E-02 10
The EASE analysis tool was used to calculate likelihood of over-
representation for annotation categories associated with a-amanitin
sensitive 2-cell transcripts. Listed in the table are EASE characterized
biological processes for annotated genes in the a-amanitin sensitive set of
genes that are detected on the MOE430 chips, with a score less than 0.05.
The number of genes in each category is shown next to the EASE score.
The genes listed in each functional category can be found in Supplemental
Table S2.
F. Zeng, R.M. Schultz / Developmental Biology 283 (2005) 40–5748Transcripts represented by 2607 Unigenes accessions are
a-amanitin-sensitive, of which 1819 are called detected by
Affymetrix MAS ‘‘present’’ call and constitute 17% of all
genes detected in the 2-cell embryo. Because we often
observe that useful information can be drawn from ex-
pression profiles (and confirmed by quantitative RT-PCR)
even with genes that have an ‘‘absent’’ call by the MAS
program, we decided to include all genes that were
significantly a-amantin-sensitive as initial candidate genes
for further analysis with more stringent filters.
Of the transcripts up-regulated between the 1- and 2-cell
stages, 60% that increased by at least a statistically
significant 1.4-fold were a-amanitin-sensitive, whereas
86% of the genes up-regulated by at least 5-fold were a-
amanitin-sensitive (Table 2). A similar number of a-
amanitin-sensitive transcripts were also found in the subset
of genes that were up-regulated in in vivo developed 2-cell
embryos. The number of a-amanitin-sensitive transcripts we
observed is higher than that reported in another study
(Hamatani et al., 2004). This may reflect different micro-
array platforms, different sets of genes on the arrays,
different culture conditions, and different statistical analyses
used in the two studies.
Expression profiles of a few genes known to be a-
amanitin-sensitive and up-regulated at the 2-cell stage
were also confirmed in our analysis; these genes include
Hsp70.1, Eif1a, U2af1-rs1, and Rpl23. The Expression
Analysis Systematic Explorer (EASE) program was then
used to identify annotation categories over-represented
among genes that were a-amanitin-sensitive in 2-cell
embryos. EASE analysis implements a statistical measure
to discover biological themes in a particular list of genes
of interest regardless of the expression levels of the
genes. Lists of genes that showed a-amanitin sensitivity
with the MAS detection filter were analyzed against all
genes detected in 2-cell embryos, whereas genes that
showed a-amanitin sensitivity without the MAS de-
tection filter were analyzed against all genes represented
on the MOE430 GeneChip set. Interestingly, the two
predominate functional categories over-represented in
the a-amanitin-sensitive genes sets are related to protein
biosynthesis, and RNA transcription and processing
(Table 3, see Supplementary Table S2 for a complete list
of genes in each functional category). In addition, cell
cycle genes were also over-represented in the 2-cell when
comparing a-amanitin-sensitive genes to all genes on theTable 2
Number of a-amanitin-sensitive genes in in vitro developed 2-cell embryos
Fold-Change (2CC/1CC) 1.4 2 3 5
2CC>1CC 2990 2944 2453 1482
2CC>1CC and
a-amanitin-sensitive
2033 2017 1815 1282
% a-amanitin-sensitive 68.0 68.5 74.0 86.5
Number of Affymetrix probe sets on the MOE430 GeneChip set that are
statistically significantly changed by at least the fold-change indicated in
the column header.MOE430 GeneChip and may underlie the shift from a
meiotic, non-proliferative phase to mitotic, proliferative
phase.
We previously reported that transcription and RNA
processing, metabolism and cell cycle genes are over-
represented among the 2-cell up-regulated genes (‘‘2-cell
transient’’), compared to the other stages examined (Zeng
et al., 2004); Hamatani et al. (2004) also noted enhanced
zygotic expression of genes involved in RNA processing.
The results reported here demonstrate that these functions
are largely due to genes transcribed by the 2-cell embryo.
More important, however, is that the results of this and our
previous study suggest that genome activation is not as
global and promiscuous as we previously proposed (Ma et
al., 2001). The basis for this proposal was that the extensive
chromatin remodeling that occurs during the first two cell
cycles provides a window of opportunity for expression of
genes not normally expressed. The function of the chroma-
tin-mediated transcriptionally repressive state that develops
in the 2-cell embryo is to extinguish expression of these
genes that are opportunistically expressed as a consequence
of ZGA. In fact, our microarray studies indicate that a large
number of genes are transiently expressed (Zeng et al.,
2004). Nevertheless, our EASE analyses suggest that
subsets of genes with particular functions, for example,
transcription and RNA processing, are selectively ex-
pressed during ZGA. Expression of such genes may pro-
vide a positive feedback mechanism to ensure that ZGA is
irreversible.
Table 4
Top 10 networks generated from IPA for a-amanitin-sensitive transcripts in the 2-cell cultured embryos
Network
ID
Genes in network Score # Focus
genes
Top categories
1 Atpi, Bat1, Cpd, Ddx18, Ddx21, Gdi2, Gm2a, H2afz, Imp-1, Jtv1, Lamp2,
Mina53, Myc, Mycn, Ndrg1, Nol5a, Pls3, Rpl9, Rpl19, Rpl21, Rpl23, Rpl27,
Rpl30, Rpl32, Rpl35, Rpl41, Rps13, Rps19, Rps20, Rps23, Rps27, Rps4x,
Sardh, Shmt1, Tde1
32 35 Cell cycle, protein synthesis, cancer
2 Apex1, Bag4, Ccnd1, Ccne1, Ccne2, Cdkn1a, Cul3, Dnaja1, Foxg1b, Hdac1,
Hes1, Hesx1, Hmgb1, Hmgb2, Hspa8, Hsph1, Jarid1b, Klf4, Mta2, Nme2,
Pax9, Pim1, Prkch, Procr, Prtn3, Rad9a, Rnf7, Set, Skp2, Terf1, Tle1, Tob1,
Topbp1, Vhl, Znf151
32 35 Cell cycle, DNA replication,
recombination, and repair, cell death
3 Aplp2, Bcl2a1, Bcl2l11, Bid, Casp3, Ccnt1, Ccnt2, Cdk9, Ceacam1, Ctsl, Dcc,
Fem1b, Gas2, Gcnt2, Gtf2f1, Gtf2f2, His1, Hla-dqb1, Hmox2, Hnrpu, Htatsf1,
Irf3, Krt8, Krt18, Mcl1, Mhc2ta, Pcaf, Ptma, Rea, Rfxank, Rfxap, Supt4h1,
Supt5h, Troap, Wee1
32 35 Gene expression, cellular
assembly and organization,
hair and skin development and
function
4 Cd38, Clk1, Cpsf1, Ddx39, Eif1a, Eif3s4, Eif3s5, Eif3s6, Eif3s8, Eif3s10, Eif3s6ip,
Eif4a2, Eif4e, Gspt1, Hmgn2, Hnrpa1, Lck, Mapk13, Mknk2, Nup214, Nxf1,
Pabpc1, Paip1, Prpf4b, Rbm8a, Rps25, Ryr1, Sfrs1, Sfrs5, Srrm1, Thoc4,
Thy1, Tnpo3, U2af1, Ubl5
32 35 Protein synthesis, RNA
post-transcriptional modification,
gene expression
5 Atf3, Bcl3, Cbx3, Cdc2, Cdc6, Cdc25c, Cdkn2c, Cdkn2d, Chek2, Csnk2a1,
Dub1, E2f6, Fgf1, Gata1, Hspa2, Junb, Lats2, Mcm3, Mcm4, Mcm6,
Orc1l, Paf53, Pck1, Polr1a, Polr1c, Polr1d, Pttg1, Pttg1ip, Rps10, Sei1,
Smarcc1, Trim28, Ube2a, Ubtf, Zfp118
32 35 Cell cycle, DNA replication,
recombination, and repair, cell death
6 Akap8, Arih1, Arih2, Blnk, C1qbp, Cbl, Crkl, Dck, Eif4el3, Fbl, Foxc2,
Icam1, Kcnab2, Mki67ip, Msn, Ncl, Pin1, Pin4, Pip5k1a, Plec1, Ppm1a,
Prkar2a, Prkca, Prkcz, Rpl10a, Rps6, Sfpq, Slc1a1, Slc2a4, Spry2, Tmpo,
Top2a, Ube2l3, Vil2, Wdr12
32 35 Cellular assembly and organization,
carbohydrate metabolism, protein
eegradation
7 Btg1, Clns1a, Ddx20, Dhx9, Dis3, Etv3, Fbl, Gemin5, Gemin6, Gemin7,
Hrmt1l2, Ipo7, Khdrbs1, Kpnb1, Kpnb3, Mep50, Nup153, Nxf1, Ran, Ranbp2,
Rangap1, Rnut1, Rpl13, Sip1, Skb1, Smndc1, Snrpb, Snrpd1, Snrpd2, Snrpd3,
Snrpf, Tec, Xpo5, Xpot, Znf259
18 27 RNA post-transcriptional
modification, cell signaling,
nucleic acid metabolism
8 Arc, Coil, Ddx20, Dhx9, Fbl, Fgf2, Fkbp3, Fmr1, Gan, Gemin4, Gemin5, H2-k,
Lamr1, Lgals1, Lgals3, Map1b, Mdk, Ncl, Nola1, Nola2, Nola3, Nolc1, Nop5/nop58,
Nufip1, Prpf8, Rpl13a, Rps7, Sip1, SmN1, Snrpb, Snrpd2, Snrpd3, Snrpe, Snrpf, Tfpt
15 25 RNA post-transcriptional
modification, cellular growth and
proliferation, gene expression
9 Apoa1, Apoe, Col11a2, Hspb1, Ipo9, Jrk, Mt1a, Myc, Mycn, Ndufa2, Pin4, Pltp,
Polr2a, Polr2b, Polr2c, Polr2d, Polr2e, Polr2f, Polr2g, Polr2h, Polr2i, Polr2j,
Polr2k, Polr2l, Rpl7, Rpl26, Rpl27a, Rps3, Rps7, Rps9, Rps11, Tbp, Xab2, Znf263
9 19 Gene expression, lipid metabolism,
cancer
10 Ascl1, Axin1, Cbx3, Cbx8, Clock, Csnk1d, Csnk1e, Dbp, Ddc, Dio1, Dvl1, Dvl1l1,
E2f6, H-l(3)mbt-like, Hdac3, Id1, Mblr, Ngfrap1, Per1, Pgd, Ppia, Ppp2ca, Prdx6,
Ring1, Ring2, Rnf134, Rrm1, Rrm2, Rybp, Senp2, Stat5b, Thrb, Yaf2, Ywhae, Yy1
9 19 Behavior, organismal development,
cellular development
Statistically significant a-amanitin sensitive genes from the 2-cell cultured embryos (a-amanitin treated vs. untreated) were used as input for IPA analysis, and
the resulting top 10 networks as well as their top 3 network function categories are shown.
Table 5
Top functional classes enriched in the a-amanitin-sensitive genes in 2-cell
cultured embryos
High-level function Significance # Global
analysis
genes
RNA post-transcriptional modification 1.75E-14–3.11E-2 58
Cell cycle 5.88E-11–4.98E-2 144
Gene expression 8.57E-9–3.14E-2 182
Protein synthesis 1.09E-8–3.47E-2 58
DNA replication, recombination, and
repair
2.59E-5–3.14E-2 116
Cell death 2.55E-4–4.76E-2 208
IPA global functional analysis was used to examine the enriched functional
classes of the a-amanitin-sensitive gene sets in the 2-cell cultured embryos.
Each of these annotated functional class listed in the left column contains
multiple subcategories and the range of significance of these subcategories
is listed in the middle column. The genes listed in each functional class can
be found in Supplemental Table S3.
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EASE analysis identified important functional cate-
gories (e.g., protein synthesis, and transcription and
RNA processes) that are over-represented in the 2-cell
a-amanitin-sensitive transcripts. EASE provides a unique
way to convert functional genomics studies from ‘‘genes
to themes’’ (Hosack et al., 2003). To gain insight into how
the individual genes in a relevant theme are interrelated or
interacting with each other in a coordinated fashion to
initiate and execute genome activation and concomitantly
form a transcriptionally repressive state, we employed
Ingenuity Pathway Analysis (IPA). IPA provides a tool to
construct and extract relevant information from the
microarray analysis and integrates individual genes, bio-
logical themes, and functional regulatory networks. An
inherent weakness of EASE and IPA is that they are
Fig. 4. Global functional category comparison of gene sets up-regulated in 2-cell embryos from in vivo or in vitro treatments. Increasing value of log
(significance) indicates increased confidence for each category. The number of genes in each category is shown above the bars. Open bars, 2C>1C (in vivo);
Solid bars, 2CC>1CC (in vitro).
Table 6
Top functional classes enriched in a-amanitin-sensitive and up-regulated
genes in in vivo developed 2-cell embryos
High level function Significance # Global
analysis
genes
RNA post-transcriptional modification 1.20E-11–3.27E-2 37
Protein synthesis 2.84E-10–2.52E-2 44
Gene expression 4.95E-7–4.72E-2 106
Cell cycle 3.56E-6–4.95E-2 72
Immune and lymphatic system
development and function
2.25E-4–2.25E-4 3
Protein folding 4.40E-4–4.40E-4 9
Lipid metabolism 7.82E-4–4.95E-2 22
Cell signaling 1.12E-3–1.12E-3 9
Nucleic acid metabolism 1.12E-3–1.12E-3 9
DNA replication, recombination, and
repair
1.34E-3–4.76E-2 47
IPA global functional analysis for genes that are derived from those
expressed higher in the 2-cell embryos than in both 1-cell and egg in vivo,
and are a-amantin-sensitive in vitro. The range of significance of the
subcategory within a function is listed in the middle next to the number of
global genes annotated with that function as in Table 5. The genes listed in
each functional class can be found in Supplemental Table S4.
F. Zeng, R.M. Schultz / Developmental Biology 283 (2005) 40–5750limited to those genes with assigned annotations or pub-
lished relationships, and depend on the accuracy of these
annotations.
Gene interaction networks were drawn from the lists of
genes that are a-amanitin-sensitive. Out of the 2607 a-
amantin-sensitive genes (genes whose expression was
reduced by 1.7- to 276.4-fold with a FDR <5%), 791 were
identified as focus genes used to generate biological
networks and 899 were used for global functional analysis.
Thirty-eight networks generated had a score of 3 or higher
and contained 12 or more focus genes (Table 4). Notably,
the top six networks identified were most significant with a
score of 32 and contained the highest number of focus genes
(35) allowed in each network. Because a score of 2 or higher
has at least a 99% confidence of not being generated
by random chance, the high confidence level associated
with the large number of genes and associated networks
demonstrates the extensive interrelation and interaction
between the genes that are turned on at the 2-cell stage.
Listed in Table 5 are the number of genes that are in the
top 6 networks and the relevant biological functions that are
represented by these networks. The top functions in which
these individual networks participate are consistent with the
global functions generated by IPA to search for the most
significant biological functions across the entire dataset of
the a-amanitin-sensitive genes, compared to the IPA know-ledge base. The IPA global functional analysis (GFA)
confirmed the EASE analysis that genes functioning in
gene expression (20.2%) and protein synthesis (6.5%), in
addition to cell cycle (16.0%) genes, are highly represented
F. Zeng, R.M. Schultz / Developmental Biology 283 (2005) 40–57 51in the a-amanitin-sensitive group. Because the IPA imple-
ments a similar but distinct statistical analysis tool to search
for global functions in the gene set, and the reference
population of annotations is also different, IPA GFA and
EASE can give complementary information. IPA revealed
that RNA post-transcriptional modification (6.5%), DNA
replication, recombination and repair (12.9%), and cell
death genes (23.1%) are also among the top six functions
present in the a-amanitin-sensitive gene set.
Before we implemented these analyses, we first deter-
mined the effect of embryo culture on gene expression,
because such effects could adversely affect interpretation of
the results. For example, genes that may be turned on in
response to the culture conditions would be detected as a-
amanitin sensitive but would not be of biological relevance
in vivo. Accordingly, we first compared the two sets of 2-
cell, up-regulated genes that were generated from in vivo
versus in vitro developed embryos to search for differences
in global functional classes that these two groups of genes
exhibit. This difference only served as a rough measure of
the biological relevance between the two groups, conside-
ring that the in vivo and in vitro developed embryos were
unlikely at precisely the same developmental stage.
Fig. 4 shows selected functional classes that are
represented by these two sets of genes that are up-regulated
in the 2-cell embryo when compared to the 1-cell embryo. A
few classes of genes are reduced or missing in cultured
embryos, and include categories for protein synthesis and
processing (protein synthesis, protein trafficking, protein
folding, post-translational modification), as well as other
processes like RNA post-transcriptional modification. The
over-representation of cell death genes may reflect a stress
response to culture. Gene expression, DNA replication, and
nucleic acid metabolism do not seem to be affected in terms
of functional representation. We focused on exploring
networks of genes whose transcripts are up-regulated in
the 2-cell embryo in vivo and a-amanitin-sensitive in order
to minimize the effect of culture on our analysis.
The lists of interest that were subjected to IPA analysis
were derived from those genes whose expression was higher
in the 2-cell embryos than in both 1-cell embryos and eggs,
besides being a-amanitin-sensitive in vitro. We filtered the
genes in the 2-cell embryo against both the 1-cell embryo
and the egg to reduce the background of maternally-derived
transcripts. The resulting 1759 genes were used for IPA and
465 focus genes were identified for network generation and
521 for global functional analysis. Global functional
analysis once again confirmed that the highest significant
functional classes in this group of genes are RNA post-
transcriptional modification (7.1%), which includes genes
functioning in processing of RNA such as splicing (50% of
this group) and polyadenylation; protein synthesis (8.4%),
gene expression (20.3%), which includes among other
categories transcription (86.8% of this group); mRNA
elongation, repression, expression of genes, recruitment,
and DNA binding; cell cycle (13.8%), which includes genesfunctioning (not exclusively) in mitotic cell cycle (66.7% of
this group), G1/S transition (30.5% of this group), G2/M
transition (23.6%), and DNA replication (19.4%) (Table 6).
This result fits the overall biological themes of embryo
development at this stage and is consistent with our previous
findings (Zeng et al., 2004). A summary of the genes in the
top two networks is found in Table 7.
IPA generated 25 networks with scores of 6 or higher and
at least 12 focus genes in the network, including the top two
networks that are most significant with a significance score
of 41 and a maximum 35 focus genes (Figs. 5 and 6).
Network 1 (Fig. 5) has an overall biological theme of
protein synthesis, and interestingly, all focus genes centered
around c-Myc (Myc). The a-amanitin-sensitivity of Myc
expression detected by the microarrays was confirmed by
real-time RT-PCR. Myc expression increased 8.3-fold from
the 1-cell to the 2-cell stage and in the presence of a-
amanitin this ratio was 0.38. This ratio of <1 was anticipated
because the zygotic Myc transcripts are not expressed in the
a-amanitin-treated embryos and maternal Myc transcripts
continued to be degraded. It should be noted that although
Myc expression was not called ‘‘present’’ in either control or
treated embryos by the Affymetrix MAS filter on flags, the
robustness of our experimental design revealed that these
differences were statistically significant. The MAS ‘‘absent’’
flag likely reflects Myc’s low level of expression and
highlights the usefulness of including lists of genes that are
not necessarily called ‘‘detected’’ (by the MAS algorithm)
for IPA as long as the differences are statistically significant.
MYC plays an important role in regulating cell cycle, cell
growth, differentiation, apoptosis, transformation, genomic
instability, and angiogenesis presumably by its ability to
activate or repress transcription of target genes that mediate
these various processes (Hipfner and Cohen, 2004). Myc-
responsive genes have identified few overlapping target
genes, except for many ribosomal genes (Boon et al., 2001).
Because ribosomes are centrally involved in macromole-
cular synthesis and metabolism, a major proposed role for
Myc is to regulate protein synthetic and metabolic pathways.
Out of the 35 genes in Network 1 (Fig. 5), 17 are ribosomal
proteins, in addition to other genes involved in ribosomal
RNA biogenesis and assembly (Ddx21 and Nol5a). This
finding is consistent with protein synthesis and ribosome
biogenesis being two major biological themes that emerge
from our EASE analyses of 2-cell embryos (Zeng et al.,
2004) and results described here.
The top network generated from the a-amanitin-sensitive
genes suggests how these functionally related genes act in a
coordinated fashion, and how the up-regulation of Myc
expression, which activates itself and hence generates
an autoactivation loop, may be critical for development
following genome activation. Consistent with this proposal
are results from a previous study that used an anti-sense
approach to ablate Myc function in 2-cell embryos post-
ZGA and observed that virtually all of the embryos arrested
at the 8-cell/morula stage (Paria et al., 1992). Moreover, our
Table 7
Summary of genes in the top 2 IPA networks
Gene Affymetrix Fold Change
2C/1C
Fold Change
2CC/2CA
Networks Description Family Location
Atpi 1448770_a_at 3.3 4.3 1 ATPase inhibitor Cytoplasm
Ddx21 1448271_a_at 5.7 2.2 1 DEAD (Asp-Glu-Ala-Asp) box
polypeptide 21
enzyme Nucleus
Glg1 1448580_at 7.9 9.8 1 Golgi apparatus protein 1 Cytoplasm
Gm2a 1448241_at 7.3 12.2 1 GM2 ganglioside activator Cytoplasm
H2afz 1416415_a_at 8.3 3.0 1 H2A histone family, member Z Nucleus
Hmox2 1416399_a_at 4.4 2.2 1 Heme oxygenase (decycling) 2 enzyme Cytoplasm
Imp-1 1418761_at 4.5 15.3 1 IGF-II mRNA-binding protein 1
Jtv1 1451262_a_at 2.2 2.3 1 JTV1 gene
Lamp2 1416343_a_at 72.8 11.5 1 Lysosomal-associated
membrane protein 2
enzyme Plasma
Membrane
Mt1a 1422557_s_at 115.6 39.9 1 Metallothionein 1A (functional) Cytoplasm
Myc 1424942_a_at 10.6 6.9 1, 4, 5, 7 v-myc myelocytomatosis viral
oncogene homolog (avian)
transcription
regulator
Nucleus
Nol5a 1455035_s_at 5.6 9.6 1 Nucleolar protein 5A
(56kDa with KKE/D repeat)
Nucleus
Pls3 1423725_at 2.5 2.5 1 Plastin 3 (T isoform) Cytoplasm
Psat1 1454607_s_at 198.2 152.7 1 Phosphoserine aminotransferase 1 enzyme Cytoplasm
Rpl7 1415979_x_at 17.6 9.2 1, 4 Ribosomal protein L7 transcription
regulator
Cytoplasm
Rpl9 1443843_x_at 85.5 51.9 1 Ribosomal protein L9 Cytoplasm
Rpl13 1460581_a_at 12.6 27.6 1 Ribosomal protein L13 Cytoplasm
Rps13 1415912_a_at 34.7 36.3 1 Ribosomal protein S13 Cytoplasm
Rpl19 1416219_at 6.9 5.7 1 Ribosomal protein L19 Cytoplasm
Rps18 1455572_x_at 8.2 7.7 1 Ribosomal protein S18 Cytoplasm
Rpl21 1429077_x_at 4.4 16.0 1 Ribosomal protein L21 Cytoplasm
Rps19 1449243_a_at 47.2 27.9 1 Ribosomal protein S19 Cytoplasm
Rpl23 1422859_a_at 37.4 6.8 1 Ribosomal protein L23 Cytoplasm
Rps20 1456436_x_at 19.0 13.2 1 Ribosomal protein S20 Cytoplasm
Rpl27 1448217_a_at 6.9 4.0 1 Ribosomal protein L27 Cytoplasm
Rps23 1460175_at 18.7 9.6 1 Ribosomal protein S23 Cytoplasm
Rpl30 1418273_a_at 6.7 6.3 1 Ribosomal protein L30 Cytoplasm
Rps27 1415716_a_at 20.5 16.1 1 Ribosomal protein S27
(metallopanstimulin 1)
Cytoplasm
Rpl35 1436840_x_at 6.9 5.0 1 Ribosomal protein L35 Cytoplasm
Rps4x 1416276_a_at 7.1 6.0 1 Ribosomal protein S4, X-linked Cytoplasm
Rpl41 1455578_x_at 31.4 5.0 1 Ribosomal protein L41 Cytoplasm
Sasdh 1416662_at 4.4 15.8 1 Sarcosine dehydrogenase enzyme Cytoplasm
Shmt1 1425179_at 72.2 33.4 1 Serine hydroxymethyltransferase 1
(soluble)
enzyme Cytoplasm
Tde1 1417815_a_at 5.1 4.3 1 Tumor differentially expressed 1 Plasma
Membrane
Znf151 1416224_at 5.7 9.5 1 Zinc finger protein 151 (pHZ-67) Nucleus
Apex1 1416135_at 2.6 2.3 2 APEX nuclease (multifunctional
DNA repair enzyme) 1
enzyme Nucleus
Asid4a 1436191_at 2.7 5.5 25, 2 AT-rich interactive domain 4A
(RBP1-like)
transcription
regulator
Nucleus
Bcos 1428773_s_at 4.1 6.0 2 BCL6 co-repressor transcription
regulator
Nucleus
Ccne1 1416492_at 15.9 10.8 19, 2 Cyclin E1 Nucleus
Ccne2 1422535_at 3.4 3.5 2 Cyclin E2 Nucleus
Cdc2 1448314_at 6.1 5.7 2, 13 Cell division cycle 2, G1 to S
and G2 to M
kinase Nucleus
Cdc6 1417019_a_at 3.5 5.5 2 CDC6 cell division cycle 6 homolog
(S. cerevisiae)
Nucleus
Cdc25c 1422252_a_at 61.8 17.7 2 Cell division cycle 25C phosphatase Nucleus
Cdk5s1 1433451_at 6.2 16.1 2 Cyclin-dependent kinase 5, regulatory
subunit 1 (p35)
Nucleus
Cdkn1a 1421679_a_at 6.8 6.8 2 Cyclin-dependent kinase inhibitor
1A (p21, Cip1)
Nucleus
Chek2 1422747_at 6.3 4.6 2 CHK2 checkpoint homolog (S. pombe) kinase Nucleus
Cul3 1422794_at 9.4 4.6 2 Cullin 3 Nucleus
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Gene Affymetrix Fold Change
2C/1C
Fold Change
2CC/2CA
Networks Description Family Location
Fkbp3 1416859_at 73.8 29.1 2 FK506 binding protein 3, 25 kDa enzyme Nucleus
Gadd45a 1449519_at 5.3 24.5 2, 6 Growth arrest and DNA-
damage-inducible, alpha
Nucleus
Gadd45b 1450971_at 10.9 14.1 2 Growth arrest and DNA-
damage-inducible, beta
Cytoplasm
Hdac1 1448246_at 16.4 8.0 2 Histone deacetylase 1 transcription
regulator
Nucleus
Klf4 1417394_at 8.6 6.2 2 Kruppel-like factor 4 (gut) transcription
regulator
Nucleus
Madh7 1423389_at 6.6 6.8 2 SMAD, mothers against DPP
homolog 7 (Drosophila)
Nucleus
Mizf 1440255_at 3.6 2.3 2 MBD2 (methyl-CpG-binding protein)-
interacting zinc finger protein
Nucleus
Mta2 1423165_a_at 8.0 15.2 25, 2 Metastasis-associated gene family,
member 2
transcription
regulator
Nucleus
Nme2 1448808_a_at 181.6 50.5 2 Non-metastatic cells 2, protein
(NM23B) expressed in
kinase Nucleus
Pim1 1435458_at 3.2 2.6 2 pim-1 oncogene kinase Cytoplasm
Ppia 1417451_a_at 4.0 2.0 2 Peptidylprolyl isomerase A
(cyclophilin A)
enzyme Cytoplasm
Pspf4b 1455696_a_at 15.1 6.4 2 PRP4 pre-mRNA processing
factor 4 homolog B (yeast)
kinase Nucleus
Pttg1 1419620_at 9.2 12.8 2 Pituitary tumor-transforming 1 transcription
regulator
Nucleus
Rnf7 1426414_a_at 8.8 10.4 2 Ring finger protein 7 Nucleus
Rps10 1434854_a_at 4.8 4.1 2 Ribosomal protein S10 Cytoplasm
Set 1421819_a_at 28.9 4.5 2 SET translocation
(myeloid leukemia-associated)
Nucleus
Sfss1 1434972_x_at 20.2 4.0 2 Splicing factor, arginine/serine-rich 1
(splicing factor 2, alternate
splicing factor)
Nucleus
Sfss5 1423130_a_at 3.1 2.9 2 Splicing factor, arginine/serine-rich 5 Nucleus
Tnpo3 1429369_at 16.2 18.5 2 Transportin 3
Tob1 1423176_at 21.0 10.5 2 Transducer of ERBB2, 1 transcription
regulator
Cytoplasm
Top2a 1454694_a_at 3.1 5.0 2 Topoisomerase (DNA) II alpha
170 kDa
enzyme Nucleus
Ube2a 1448772_at 7.3 4.5 2 Ubiquitin-conjugating enzyme
E2A (RAD6 homolog)
enzyme Cytoplasm
Yy1 1422569_at 25.4 18.7 2 YY1 transcription factor transcription
regulator
Nucleus
Table 7 (continued)
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(with a score of 9 and higher) that represent many different
biological themes, as well as the ability to activate or repress
either directly or indirectly many core genes in the other
networks (e.g., the cell cycle regulatory genes cyclin E,
Cdc2 in Network 2) demonstrates the extent that Myc can
regulate multiple subsets of genes to elicit specific genetic
programs. Thus, once the genome is activated, presumably
by maternally-derived components, Myc may be a seminal
component involved in expression of numerous genes that
are critical for continued development.
Superimposed on genome activation is the development
of a chromatin-based transcriptional repressive state in the
2-cell embryo (see Introduction) that is relieved by inducing
histone hyperacetylation. This finding implicates histone
deacetylases (HDACs) as major players responsible for the
repressive state, but which member(s) of the Hdac familyare responsible has remained elusive, because the HDAC
inhibitors used were not isoform-specific (Aoki et al., 1997;
Davis et al., 1996; Henery et al., 1995; Wiekowski et al.,
1993). Our results suggest that expression of Hdac1 may be
central to the development of the transcriptionally repressive
state.
HDAC1 has the most number of interactions (11) with
other focus genes in Network 2, which has an overall
functional theme for cell cycle and DNA replication (Fig.
6). Expression profiles of all the HDACs present on the
Affymetrix MOE430 GeneChips (including Hdac1, 2, 3, 5,
6, 7a, 8, 10, and 11) reveals that only Hdac1 is a-amanitin-
sensitive, a finding confirmed by real-time RT-PCR. Hdac1
abundance increases 1.6-fold between the 1-cell and 2-cell
stages, but that this ratio is 0.1 when a-amanitin is present;
as with Myc, the ratio of less than 1 was anticipated and
likely reflects degradation of maternal Hdac1 transcripts.
Fig. 5. Top interaction Network 1. Network 1 is from IPA analysis of gene sets up-regulated in 2-cell embryos compared to 1-cell embryos and eggs and are
also a-amanitin-sensitive. The network is displayed graphically as nodes (gene or gene product) and edges (the biological relationships between nodes,
including functional or physical interactions, e.g., E, expression; B, binding). The numbers under a node are the fold-change of 2C over 1C (up-regulation, top
number) and 2CC over 2CA (a-amanitin-sensitive, bottom number). See Table 7 for a complete description of the genes. The shape of the objects (e.g., circle,
diamond) represents whether the protein is a structural protein, transcription factor, etc. and the family classes represented by these shapes are listed in Table 7.
The greater the color intensity, the greater the up-regulation in the 2-cell relative to the 1-cell embryo in vivo.
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by this network and include, among the 11 genes that show
physical interaction with HDAC1: MTA2, which is a
component of the nucleosome remodeling deacetylase
complex NuRD (which also includes HDAC1) that is
involved in chromatin assembly/disassembly (Ng and Bird,
2000); ARID4A, a nuclear protein that can serve as a
bridging molecule to recruit HDACs and provides a second
HDAC-independent repression function (Wilsker et al.,
2002); BCOR (BCL6 co-repressor) that selectively interacts
with transcription repressor BCL6 and can bind to specific
class I and II HDACs (Bertos et al., 2001); MIZF interacts
with MBD2, which is a component of MeCP1 (MBD2)–
HDAC complex and plays a role in DNA methylation and
transcription repression (Sekimata and Homma, 2004;
Sekimata et al., 2001); and YY1 (Yin Yang 1), whichactivates or represses transcription by binding with many
other factors (Thomas and Seto, 1999), and interestingly,
translocates from the cytoplasm of 1-cell embryos to the
nucleus in 2-cell embryos (Donohoe et al., 1999), that is,
when the transcriptionally repressive state develops. The
a-amanitin-sensitivity of Mta2 and Yy1 was confirmed by
real-time RT-PCR (data not shown).
The network data, functions, and interactions to build
these networks were generated from different experimental
systems, such as cell-free systems, in vitro culture of normal
or cancer cells, and/or in other animal models, and hence the
applicability of these results in the preimplantation embryo
awaits validation. Nevertheless, the results presented here
that employ microarray analysis of gene expression, coupled
with EASE and IPA, highlight the power of this hypothesis-
generating approach to identify candidate genes that
Table 8
Cross-platform analysis of a-amanitin-sensitive genes in 2-cell embryos
MOE430 2CC>1CC (>1.4) MOE430 2CC>1CC (>5)
NIA+ NIA NIA+ NIA
MOE+ 288 (69.6%) 12 (2.9%) 179 (84.0%) 9 (4.2%)
MOE 110 (26.6%) 4 (1.0%) 24 (11.3%) 1 (0.5%)
MOE430 2CC>1CC (>1.4) refers to genes that are up-regulated by at
least a 1.4-fold between 1-cell and 2-cell stages in the MOE set that are
common in the MOE430 and combined NIA set. MOE430 2CC>1CC
(>5) refers to genes that are up-regulated by at least a 5-fold in the MOE
set between the 1-cell and 2-cell stages that are common in the MOE and
combined NIA set. MOE+ and NIA+ are genes that are a-amanitin-
sensitive, whereas MOE and NIA are genes that are a-amanitin-
insensitive. The number of genes in each category is shown and the
numbers in parentheses correspond to the fraction of genes in this category
when compared to the total number in all four categories.
Fig. 6. Top interaction Network 2. Network 2 is from IPA analysis of gene sets up-regulated in 2-cell embryos compared to 1-cell embryos and eggs and is also
a-amanitin-sensitive. See legend to Fig. 5 for details.
F. Zeng, R.M. Schultz / Developmental Biology 283 (2005) 40–57 55will be the subject of a hypothesis-driven approach. We are
currently pursuing the role of Myc and Hdac1 as critical
players in genome activation and repression, respectively, in
the preimplantation mouse embryo.
Cross-platform analysis
There is a growing concern about the reproducibility of
data sets obtained from microarray experiments, and the
ability to merge existing data sets, especially when the
experiments used different platforms (Marshall, 2004). To
determine the concordance in a-amanitin-sensitive genes
that we detected to that described in another study that used
long oligos based on preimplantation and post-implantation,
and ovarian cDNA libraries (Hamatani et al., 2004), we first
identified the common set of genes expressed in 2-cell
embryos and then determined the fraction of a-amanitin-
sensitive genes common to both sets (Table 8). Note that
although 2990 Affymetrix MOE430 probe sets are up-
regulated by at least 1.4-fold in the 2-cell embryo, only 15%
are present in the up-regulated NIA set. This complicates across-platform comparison because different genes are being
assayed with different platforms. Despite the differences in
both experimental design and the criteria employed to
identify a-amanitin-sensitive genes, the concordance was
quite high in the set of commonly up-regulated genes. For
F. Zeng, R.M. Schultz / Developmental Biology 283 (2005) 40–5756example, using genes that displayed only a 1.4-fold increase
between the 1-cell and 2-cell stages (Table 2), ¨70% of the
commonly detected genes in 2-cell embryos are also a-
amanitin-sensitive. When at least a 5-fold increase in
expression between the 1-cell and 2-cell stages (Table 2)
was employed, the overlap in a-amanitin-sensitive genes
was 84%. The common set of a-amanitin-sensitive genes is
found in Table S6. The consistency of these results between
the two studies provides reassurance that using microarrays
to analyze gene expression in preimplantation mouse
embryos has been and will be a valid and powerful
approach to study gene expression during preimplantation
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